Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: Possible role of the resistin and adiponectin
- 1 January 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 339 (4), 1190-1196
- https://doi.org/10.1016/j.bbrc.2005.11.143
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Adipose Tissue as an Endocrine OrganJournal of Clinical Endocrinology & Metabolism, 2004
- Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetesMetabolism, 2003
- PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived ProteinDiabetes, 2001
- Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body WeightBiochemical and Biophysical Research Communications, 2000
- Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes MellitusAnnals of Internal Medicine, 1998
- Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDMDiabetes, 1997
- Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes, 1997
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995